JSUMC provides many outlets for residents to receive and provide feedback. During clinical rotations, residents are supervised by attending physicians and direct feedback is provided at the end of each rotation.

The program has a jeopardy system in place for every class. Each resident will be on jeopardy for approximately 4 weeks out of the year where they may be pulled to cover any unanticipated needs in core rotations. These residents carry on as usual unless additional coverage is needed.

There is no difference in scheduling for categorical or preliminary/transitional year interns. All interns are treated as part of the same team and complete the same rotations. If alternative accommodations are needed for program specific requirements (ex. emergency medicine experience for anesthesia), we accommodate those requests as best as possible.

Our reports are designed to highlight FDA-approved therapies, relevant clinical trials, and NCCN-guided treatment options, supporting evidence-based decisions at the point of care.

We offer testing solutions that require smaller sample sizes and deliver faster results than many traditional methods, helping you initiate treatment without unnecessary delays.

We provide reports through a secure provider portal and support integration with electronic health records (EHRs) in both HL7 and PDF formats.

Our genomic tests are covered by Medicare and most major insurers. We also offer direct support to your billing and pathology teams to streamline the reimbursement process.

Our team of molecular pathology experts is available for consultation on test selection, sample handling, and interpretation of complex results to ensure optimal clinical utility.

Anthology Diagnostics was founded in partnership with Hackensack Meridian Health and Genomic Testing Cooperative to bring comprehensive genomic profiling for cancer to the local New Jersey community and east coast.

Anthology Diagnostics operates out of the JFK Medical Center and serves physicians, patients, hospitals and local labs to help advance precision medicine.

We provide tumor profiling for solid tumors and hematologic malignancies. Liquid biopsy testing is also available.

Anthology Diagnostics offers local state-of-the-art genomic profiling analyzing both DNA and RNA.

Our Precision Diagnostics offering utilizes the most advanced technology and software with deep learning to deliver advances in disease detection, prognosis and therapy recommendations. Our high-quality testing requires less tissue, provides faster results and is more cost efficient and affordable. 

Anthology Diagnostics molecular profile tests are well validated and covered by Medicare and most major insurances.

Anthology Diagnostics is part of the Genomic Testing Cooperative network of laboratories.

GTC in collaboration with Anthology Diagnostics allows laboratories, health systems and Oncology groups to join this network, share resources, share knowledge, and collaborate in a community environment.

The GTC model produces big data for AI analysis creating value for hospitals, research, drug development, and others involved in cancer care.